Antipsychotics : history, science, and issues / Jeffrey Kerner and Bridget McCoy.

Author: Kerner, Jeffrey, author.

Imprint:Santa Barbara, California : Greenwood, an Imprint of ABC-CLIO, LLC, [2017]

Descriptionxv, 234 pages ; 25 cm.

Note:ch. 1: Case studies -- Case 1: Jimmy -- Case 2: Bobby -- Case 3: George -- ch.2: What are antipsychotics? -- Psychotic disorders and the symptoms of psychosis -- Treatment of psychosis: from exorcism to antipsychotics -- Typical antipsychotics: the beginning -- Atypical antipsychotics: as the story continues... -- ch.3. Antipsychotics: a brief history -- Early biological remedies: the original antipsychotics -- "A drug in search of an illness": developing antipsychotic medications -- Chlorpromazine rises -- Side effects emerge -- Competition for chlorpromazine -- How antipsychotics are used today: bridging past and future -- ch.4: How antipsychotics work -- Parts of the brain -- What are neurotransmitters and what do they do? -- Neurotransmitters affected by antipsychotics -- Other potential targets -- ch.5: Effects and applications -- Therapeutic effects of antipsychotics -- How well do antipsychotics work? -- Indications for medical use -- Antipsychotic use in special groups -- ch.6: Risks, misuse, and overdose -- Side effects -- Misuse of antipsychotics -- Antipsychotic overdose and toxicity -- ch.7: Production, distribution, and regulation -- Pharmaceutical industry -- Antipsychotics in nursing homes -- Prior authorization -- The unique case of clozapine -- AIMS and metabolic monitoring -- ch.8: The social dimensions of antipsychotics -- Deinstitutionalization -- Antipsychotics and the doctor-patient relationship -- Legal and ethical implications of antipsychotics -- Antipsychotics and political dissent -- Antipsychotics and the elderly -- Antipsychotics and children -- When to treat? The implications of the initiation of antipsychotic treatment -- The business of antipsychotics -- Mental illness and violence -- ch. 9: The future of antipsychotics -- Where are antipsychotics failing? -- Pathophysiology of chronic psychotic disorders -- New medications on the horizon -- Better routes of administration -- Use in nonpsychotic disorders.

Bibliography Note:Includes bibliographical references (pages 217-219) and index.

This item has been checked out 1 time(s)
and currently has 0 hold request(s).